Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Safety, Tolerability, and Efficacy of Deferasirox in MDS

NCT00469560

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • SOC EMATOLOGIA ASO SS Antonio e Biagio Alessandria, Italy
  • Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy
  • CTMO-Ematologia Ospedale Binaghi Cagliari, Italy
  • Ospedale "A. Businco" Cagliari, Italy
View all 17 locations
View Trial Details
Completed

Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.

NCT01718379

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations
  • Hematology Dpt, Service d'Hématologie Clinique CHU Albert Michallon, Grenoble, France
  • Hematology Dpt, CHR La Source orléans Orléans, France
  • Chu Amiens Amiens, France
  • CHU Angers Angers, France
View all 48 locations
View Trial Details
Completed

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

NCT01772953

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Children's Hospital of Alabama/UAB Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details
Completed

Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00121303

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • North Hampshire Hospital Basingstoke, England, United Kingdom
  • Kent and Canterbury Hospital Canterbury, England, United Kingdom
  • Medway Maritime Hospital Gillingham Kent, England, United Kingdom
  • Maidstone Hospital Maidstone, England, United Kingdom
View Trial Details
Completed

APG101 in Myelodysplastic Syndrome

NCT01736436

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Universitaetsklinik Heidelberg, Medizinische Klinik V, Haematologie, Onkologie & Rheumatologie Heidelberg, Germany
  • Universitaetsmedizin Mannheim, III. Medizinische Klinik, Haematologie und Onkologie Mannheim, Germany
View Trial Details

Related conditions